Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study

Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study

BackgroundBloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have received much attention. However, few studies have identified risk factors for CRKP BSIs in comparison to CRKP non-bloodstream infections (non-BSIs). This study aimed to compare the epidemiology,...

Full description

Bibliographic Details
Main Authors:	Xiangyuan Sun, Xiaocui Zou, Boting Zhou, Tao Yin, Ping Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Medicine
Subjects:	Carbapenem resistance Klebsiella pneumoniae bloodstream infection non-bloodstream infection intensive care unit
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1230721/full

Similar Items

Risk factors and prognosis of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in ICU patients: a report of 81 cases
by: LIU Meng, XU Wen, DAI Yunqi, TAN Ruoming, LIU Jialin, GU Feifei, CHEN Erzhen, WANG Xiaoli, QU Hongping, QIU Yuzhen
Published: (2023-09-01)

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
by: Meng H, et al.
Published: (2022-08-01)

Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China
by: Liang X, et al.
Published: (2022-06-01)

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
by: Zhang P, et al.
Published: (2020-09-01)

Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection: A Five-Year Retrospective Study
by: Cao Z, et al.
Published: (2022-02-01)

Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China
by: Yuanyuan Li, et al.
Published: (2020-06-01)

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
by: Qiqiang Liang, et al.
Published: (2019-05-01)

Protective efficacy of statins in patients with Klebsiella pneumoniae bloodstream infection
by: Qian Xu, et al.
Published: (2023-01-01)

Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study
by: Jie Chen, et al.
Published: (2022-12-01)

Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla KPC, virulence factors and their impacts on clinical outcome
by: Min Xu, et al.
Published: (2018-07-01)

Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy
by: Lucia Brescini, et al.
Published: (2019-07-01)

Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Co-Harboring blaKPC-Carrying Plasmid and pLVPK-Like Virulence Plasmid in Bloodstream Infections
by: Fang-ling Du, et al.
Published: (2021-03-01)

Colistin monotherapy or combination for the treatment of bloodstream infection caused by Klebsiella pneumoniae: a systematic review and meta-analysis
by: Tao Wang, et al.
Published: (2024-02-01)

Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing
by: Guojie Zhang, et al.
Published: (2020-11-01)

Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients
by: Ye Zhang, et al.
Published: (2018-05-01)

Ceftazidime/Avibactam, Polymyxin or Tigecycline as a Rescue Strategy for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae in Bloodstream Infection: A Retrospective Cohort Study
by: Fang Y, et al.
Published: (2023-05-01)

Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital
by: Na Zhang, et al.
Published: (2022-10-01)

Factors Associated with Extended-Spectrum β-Lactamases and Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Bloodstream Infections: A Five-Year Retrospective Study
by: Andreas G. Tofarides, et al.
Published: (2023-10-01)

Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy
by: Daniela Loconsole, et al.
Published: (2020-06-01)

Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
by: Ching-Lung Lo, et al.
Published: (2017-06-01)

Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study
by: Yili Chen, et al.
Published: (2022-07-01)

Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
by: Wenqiang Kong, et al.
Published: (2023-02-01)

Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis
by: Huan Zhang, et al.
Published: (2023-03-01)

Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010–2019)
by: Cailin Liu, et al.
Published: (2022-06-01)

Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China
by: Peiyao Jia, et al.
Published: (2022-10-01)

Successful treatment of a Carbapenem-resistant Klebsiella pneumoniae carrying blaOXA-48, blaVIM-2, blaCMY-2 and blaSHV- with high dose combination of imipenem and amikacin
by: Zied Hajjej, et al.
Published: (2016-01-01)

Molecular Epidemiology, Clinical Characteristics and Risk Factors for Bloodstream Infection of Multidrug-Resistant Klebsiella pneumoniae Infections in Pediatric Patients from Tianjin, China
by: Hou M, et al.
Published: (2022-12-01)

Genomic insight of extremely drug-resistant Klebsiella pneumoniae ST5378 from a paediatric bloodstream infection
by: Rajesh Kumar Sahoo, et al.
Published: (2023-06-01)

Development of risk factor-based scoring system for detection of hypervirulent Klebsiella pneumoniae bloodstream infections
by: Atsushi Togawa, et al.
Published: (2020-07-01)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
by: Matthew E. Falagas, et al.
Published: (2014-07-01)

Molecular epidemiology and clinical impact of Klebsiella spp. causing bloodstream infections in Hong KongResearch in context
by: Xuemei Yang, et al.
Published: (2024-03-01)

Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa
by: Qingqing Fang, et al.
Published: (2019-04-01)

The role of diabetes mellitus in patients with bloodstream infections
by: C Kaech
Published: (2008-09-01)

Drug Susceptibility and Molecular Epidemiology of Klebsiella pneumoniae Bloodstream Infection in ICU Patients in Shanghai, China
by: Shuzhen Xiao, et al.
Published: (2021-10-01)

Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection
by: Juan Chen, et al.
Published: (2023-03-01)

Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study
by: Chu W, et al.
Published: (2022-10-01)

Characterization of an IMP-4-Producing Klebsiella pneumoniae ST1873 Strain Recovered from an Infant with a Bloodstream Infection in China
by: Xu J, et al.
Published: (2020-03-01)

Association of full blood count findings with risk of mortality in children with Klebsiella pneumoniae bloodstream infection at a south african children’s hospital
by: Johanna T Shapaka, et al.
Published: (2023-06-01)

Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection
by: Jie Cheng, et al.
Published: (2022-10-01)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
by: Zhenwei Yu, et al.
Published: (2022-12-01)